Please assess the completion status of the following clinical trial:

Trial Title: Embozene Microspheres for Uterine Fibroid Embolization (UFE)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is able to provide informed consent and must sign the Institutional Review Board approved Informed Consent Form.~* Pre-menopausal women age 30-50 years at time of enrollment~* Have been selected forUterine Fibroid Embolization (UFE) prior to entry to the study.~Exclusion Criteria:~* Patient has a history of pelvic malignancy~* Patient has an abnormal Pap smear within 12 months of the planned Uterine Fibroid Embolization procedure~* Patient with coexisting condition that might explain abnormal bleeding (including endometrial hyperplasia and adenomyosis) or pelvic pain (including endometriosis and ovarian cysts).~* Is at substantial risk for the need of organ transplantation, such as renal insufficiency.~* Patient has evidence of current or recent pelvic inflammatory disease or uterine infection.~* Patient with a severe contrast allergy or renal insufficiency that would represent a contradiction to the administration of iodine-based contrast agents.~* Patients unable to comply with the follow-up requirements of the study.

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Embozene® Microspheres (Type: EXPERIMENTAL): Uterine Fibroid Embolization (UFE)will be used to treat the fibroids. The procedure involves injecting embolizing particles into the uterine artery which causes the fibroid to shrink.
- Embosphere® (Type: ACTIVE_COMPARATOR): Uterine Fibroid Embolization (UFE)will be used to treat the fibroids. The procedure involves injecting embolizing particles into the uterine artery which causes the fibroid to shrink.

Based on this trial design, predict the completion outcome and termination type (if applicable).